Biochemical and Structural Characterization of (South)-Methanocarbathymidine That Specifically Inhibits Growth of Herpes Simplex Virus Type 1 Thymidine Kinase-transduced Osteosarcoma Cells
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (31) , 32832-32838
- https://doi.org/10.1074/jbc.m313343200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Elimination of Leukemia in the Absence of Lethal Graft-Versus-Host Disease After Allogenic Bone Marrow TransplantationThe Journal of Immunology, 2003
- Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of ApplicationCurrent Gene Therapy, 2003
- Current Progress in Suicide Gene Therapy for CancerWorld Journal of Surgery, 2002
- In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical TrialHuman Gene Therapy, 1999
- Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cellsNature Medicine, 1997
- Adenoviral-Mediated Herpes Simplex Virus Thymidine Kinase Gene TransferPancreas, 1997
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Gene therapy for glioblestome multiforme: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovirJournal of Molecular Medicine, 1997
- Gene Therapy for Cancer: What Have We Done and Where Are We Going?JNCI Journal of the National Cancer Institute, 1997
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994